Mackay Shields LLC Axsome Therapeutics, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $223,640 - $325,760	-4,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $265,240 - $346,080	4,000 New	4,000 $326,000
Q2 2020 Jul 31, 2020	SELL	$49.87 - $98.69 $458,804 - $907,948	-9,200 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$41.2 - $101.31 $238,960 - $587,598	5,800 Added 170.59%	9,200 $541,000
Q4 2019 Feb 11, 2020	BUY	$16.71 - $106.24 $56,814 - $361,216	3,400 New	3,400 $352,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.01B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.